One of the largest beauty retailers in the U.S. reported first-quarter results that came ahead of the consensus
The premier beauty destination for cosmetics, fragrance, and various beauty products, Ulta Beauty announced earnings per share of $4.07, beating by far the $1.93 initially touted. The market was looking for an EPS of $1.93 on revenues of $1.64 billion. Ulta officials had the following things to say: "The net sales increase during the first quarter of fiscal 2021 was primarily due to the favourable impact in the U.S. from improving consumer confidence, government stimulus payments and the easing of COVID-19 restrictions." At the same time, the company's comparable sales went up 65.9% versus the 40.1% estimated by analysts.
For the full year 2021, Ulta Beauty's comparable sales are expected to increase between 23% - 25%, up from a previous outlook of 15% - 17%. Moreover, the EPS is seen at a high of $11.95 on revenues of $7.8 billion. The economic reopening is expected to boost the recovery in demand.
After the news, Ulta Beauty shares gained 5%.
Sources: cnbc.com, investing.com
This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.
You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.
This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com
JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.